Multiple sclerosis lesion detection in the brain: A comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin echo

Neurology

Volumn 49, Issue 2, 1997, Pages 364-370

  Gawne Cain, M L ^a   O'Riordan, J I ^a   Thompson, A J ^a   Moseley, I F ^b   Miller, D H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b National Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTRON SPIN RESONANCE; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0030820189     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.2.364     Document Type: Article

References (30)

1. Paty DW. Multiple sclerosis: assessment of disease progression and effects of treatment. Can J Neurol Sci 1987; 14(suppl):S518-S520.
2. Paty DW, Li DK, Oger JJF, et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann Neurol 1994;36(suppl):S95-S96.
3. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16.
4. Paty DW, Li DKB, the UBC MS/MRI Study Group, The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:662-667.
5. IFNB Multiple Sclerosis Study Group, University of British Columbia MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;45:1277-1285.
6. Hennig J, Naureth A, Friedburg H. RARE imaging: a fast imaging method for clinical MR. Magn Reson Med 1986;3: 823-833.
7. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic cri-teria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
8. Thompson AJ, Kermode AG, MacManus D, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance study. BMJ 1990;300:631-634.
9. Rydberg JN, Hammond CA, Grimm RC, et al. Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence. Radiology 1994;193:173-180.
10. Rydberg JN, Riederer SJ, Rydberg CH, Jack CR. Contrast optimization of fluid-attenuated inversion recovery (FLAIR) imaging. Magn Reson Med 1995;34:868-877.
11. Gawne-Cain ML, Silver NC, Moseley IF, Miller DH. Fast FLAIR in the brain: the range of appearances in normal subjects and its application to quantification of white matter disease. Neuroradiology 1997;39:243-249.
12. Plummer DL. Dispimage: a display and analysis tool for medical images. Rivista di Neuroradiologia 1992;5:489-495.
13. Bradley WG, Chen D, Georgen SK, Tam JK, Dubin MD, Pema PJ. Use of thin-section fast FLAIR to evaluate multiple sclerosis [abstract]. Radiology 1994;183:320.
14. Litt AW, Moore JR. Improved detection of white matter pathology with turbo-FLAIR MR imaging [abstract]. Radiology 1994;193(suppl):320.
15. Hashemi RH, Bradley WG, Dar-Yeong C, et al. Suspected multiple sclerosis: MR imaging with a thin-section fast FLAIR pulse sequence. Radiology 1995;196:505-510.
16. Thorpe JW, Barker GJ, MacManus DG, Moseley IF, Tofts PS, Miller DH. Detection of multiple sclerosis by magnetic resonance imaging. Lancet 1994;344:1235.
17. Hajnal JV, De Coene B, Lewis PD, et al. High signal regions in normal white matter shown by heavily T2-weighted CSF nulled IR sequences. J Comput Assist Tomogr 1992;16:506-513.
18. Constable RT, Anderson AW, Zhong J, Gore JC. Factors influencing contrast in fast spin-echo MR imaging. Magn Reson Imaging 1992;10:497-511.
19. Constable RT, Gore JC. The loss of small objects in variable TE imaging: implications for FSE, RARE, and EPI. Magn Reson Med 1992;28:9-24.
20. Stevenson VL, Gawne-Cain ML, Barker GJ, Thompson AJ, Miller DH. Imaging of the spinal cord and brain in multiple sclerosis: a comparison study between fast FLAIR and fast spin echo. J Neurol 1997;244:119-124.
21. Iacomis D, Osbakken M, Gross G. Spin-lattice relaxation (T1) times of cerebral white matter in multiple sclerosis. Magn Reson Med 1986;3:194-202.
22. Larsson HBW, Frederiksen J, Kjaer L, Henriksen O, Olesen J. In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magn Reson Med 1988;7:43-45.
23. Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988;38:1822-1825.
24. Bowen BC, Barker WW, Loewenstein DA, Sheldon J, Duara R. MR signal abnormalities in memory disorder and dementia. AJR Am J Roentgenol 1990;154:1285-1292.
25. Kappos L, Stadt D, Ratzka M, et al. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis. Neuroradiology 1988;30:299-302.
26. Kiel MK, Greenspan B, Grossman RI. Magnetic resonance imaging and degree of disability in multiple sclerosis. Arch Phys Med Rehabil 1988;69:11-13.
27. Weinshenker BG. The natural history of multiple sclerosis. Neurol Clin 1995;13:119-146.
28. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
29. Willoughby EW, Paty DW. Scales for rating impairment in multiple sclerosis: a critique. Neurology 1988;38:1793-1798.
30. Baumhefner RW, Tourtellotte WW, Syndulko K, Waluch V, Ellison GW, Meyers LW. Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging: its correlation with clinical parameters, evoked potentials and intrablood-brain-barrier IgG synthesis. Arch Neurol 1990;47: 19-26.